Biogen wins appeal for patent protection of blockbuster drug
Forward Pharma ’s challenge to Biogen’s patent on its blockbuster multiple sclerosis medication Tecfidera has been officially thwarted.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Multiple Sclerosis | Pharmaceuticals